Anxiety with depression: a treatment need.

Area of Science:

• Psychiatry
• Clinical Psychology
• Pharmacology

Background:

• Depression and anxiety are highly prevalent in the community.
• The relationship between depression and anxiety is complex and debated.
• Classical views proposed separate treatments for depression and anxiety.

Purpose of the Study:

• To review the relationship between co-occurring depression and anxiety.
• To highlight the socioeconomic burden of comorbid anxiety and depression.
• To discuss effective treatment strategies for these conditions.

Main Methods:

• Literature review examining the interplay of depression and anxiety.
• Analysis of different models for their co-occurrence (comorbidity, predisposition, shared cause, overlap).
• Discussion of pharmacological interventions.

Main Results:

• Co-occurrence can manifest as 'pure' comorbidities, reciprocal predisposition, shared etiology, or classification overlap.
• A mixed anxiety and depressive disorder with subthreshold symptoms is recognized.
• Selective serotonin reuptake inhibitors (SSRIs), such as paroxetine, are effective treatments.

Conclusions:

• Effective treatment for comorbid anxiety and depression is crucial due to significant socioeconomic burden.
• SSRIs, particularly paroxetine, are highlighted as a key pharmacological approach.
• Understanding the complex relationship is vital for improved patient outcomes.